These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 39078273

  • 1. Illicit Fentanyl Use and Hepatitis C Virus Seroconversion Among People Who Inject Drugs in Tijuana and San Diego: Results From a Binational Cohort Study.
    Friedman JR, Abramovitz D, Skaathun B, Rangel G, Harvey-Vera A, Vera CF, Artamonova I, Muñoz S, Martin NK, Eger WH, Bailey K, Go BS, Bourgois P, Strathdee SA.
    Clin Infect Dis; 2024 Oct 15; 79(4):1109-1116. PubMed ID: 39078273
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Cross-border injection drug use and HIV and hepatitis C virus seropositivity among people who inject drugs in San Diego, California.
    Horyniak D, Wagner KD, Armenta RF, Cuevas-Mota J, Hendrickson E, Garfein RS.
    Int J Drug Policy; 2017 Sep 15; 47():9-17. PubMed ID: 28683432
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Modeling the impact of a supervised consumption site on HIV and HCV transmission among people who inject drugs in three counties in California, USA.
    Killion JA, Jegede OS, Werb D, Davidson PJ, Smith LR, Gaines T, Graff Zivin J, Zúñiga ML, Pines HA, Garfein RS, Strathdee SA, Rivera Saldana C, Martin NK.
    Int J Drug Policy; 2024 Oct 15; 132():104557. PubMed ID: 39213827
    [Abstract] [Full Text] [Related]

  • 6. Hepatitis C Virus seroconversion among persons who inject drugs in relation to primary care physician visiting: The potential role of primary healthcare in a combined approach to Hepatitis C prevention.
    Artenie AA, Roy É, Zang G, Jutras-Aswad D, Bamvita JM, Puzhko S, Daniel M, Bruneau J.
    Int J Drug Policy; 2015 Oct 15; 26(10):970-5. PubMed ID: 26005038
    [Abstract] [Full Text] [Related]

  • 7. Evaluating the impact of Mexico's drug policy reforms on people who inject drugs in Tijuana, B.C., Mexico, and San Diego, CA, United States: a binational mixed methods research agenda.
    Robertson AM, Garfein RS, Wagner KD, Mehta SR, Magis-Rodriguez C, Cuevas-Mota J, Moreno-Zuniga PG, Strathdee SA, Proyecto El Cuete IV and STAHR II.
    Harm Reduct J; 2014 Feb 12; 11():4. PubMed ID: 24520885
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Associations between perceived illicit fentanyl use and infectious disease risks among people who inject drugs.
    Lambdin BH, Bluthenthal RN, Zibbell JE, Wenger L, Simpson K, Kral AH.
    Int J Drug Policy; 2019 Dec 12; 74():299-304. PubMed ID: 31733979
    [Abstract] [Full Text] [Related]

  • 11. Prevalence and risk factors associated with HIV/hepatitis B and HIV/hepatitis C co-infections among people who inject drugs in Mozambique.
    Semá Baltazar C, Boothe M, Kellogg T, Ricardo P, Sathane I, Fazito E, Raymond HF, Temmerman M, Luchters S.
    BMC Public Health; 2020 Jun 03; 20(1):851. PubMed ID: 32493347
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Water, sanitation and hygiene insecurity predict abscess incidence among people who inject drugs in a binational US-Mexico metropolitan area: A longitudinal cohort study.
    Calderón-Villarreal A, Abramovitz D, Avelar Portillo LJ, Goldenberg S, Flanigan S, Quintana PJE, Harvey-Vera A, Vera CF, Rangel G, Strathdee SA, Kayser GL.
    Int J Drug Policy; 2024 Jul 03; 129():104485. PubMed ID: 38901113
    [Abstract] [Full Text] [Related]

  • 14. Drug checking in the fentanyl era: Utilization and interest among people who inject drugs in San Diego, California.
    Bailey K, Abramovitz D, Artamonova I, Davidson P, Stamos-Buesig T, Vera CF, Patterson TL, Arredondo J, Kattan J, Bergmann L, Thihalolipavan S, Strathdee SA, Borquez A.
    Int J Drug Policy; 2023 Aug 03; 118():104086. PubMed ID: 37295217
    [Abstract] [Full Text] [Related]

  • 15. Cost-effectiveness of hepatitis C virus (HCV) elimination strategies among people who inject drugs (PWID) in Tijuana, Mexico.
    Marquez LK, Fleiz C, Burgos JL, Cepeda JA, McIntosh C, Garfein RS, Kiene SM, Brodine S, Strathdee SA, Martin NK.
    Addiction; 2021 Oct 03; 116(10):2734-2745. PubMed ID: 33620750
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Is hepatitis C virus (HCV) elimination achievable among people who inject drugs in Tijuana, Mexico? A modeling analysis.
    Marquez LK, Cepeda JA, Bórquez A, Strathdee SA, Gonzalez-Zúñiga PE, Fleiz C, Rafful C, Garfein RS, Kiene SM, Brodine S, Martin NK.
    Int J Drug Policy; 2021 Feb 03; 88():102710. PubMed ID: 32165050
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Water, sanitation, and hygiene access among people who inject drugs in Tijuana and San Diego in 2020-2021: a cross-sectional study.
    Calderón-Villarreal A, Avelar Portillo LJ, Abramovitz D, Goldenberg S, Flanigan S, Quintana PJE, Harvey-Vera A, Vera CF, Rangel G, Strathdee SA, Kayser GL.
    Int J Equity Health; 2024 Apr 22; 23(1):79. PubMed ID: 38644494
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.